Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Bronchodilator
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Anticholinergics== {{main article|Anticholinergics}} Some examples of anticholinergics are [[tiotropium]] (Spiriva) and [[ipratropium|ipratropium bromide]].{{citation needed|date=February 2022}} Tiotropium is a long-acting, 24-hour, anticholinergic bronchodilator used in the management of [[chronic obstructive pulmonary disease]] (COPD). Only available as an inhalant, ipratropium bromide is used in the treatment of asthma and COPD. As a short-acting anticholinergic, it improves lung function and reduces the risk of exacerbation in people with symptomatic asthma.<ref>{{cite journal | vauthors = Price D, Fromer L, Kaplan A, van der Molen T, Román-Rodríguez M | title = Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma? | journal = npj Primary Care Respiratory Medicine | volume = 24 | issue = 1 | pages = 14023 | date = July 2014 | pmid = 25030457 | doi = 10.1038/npjpcrm.2014.23 | pmc = 4373380 }}</ref> However, it will not stop an asthma attack already in progress. Because it has no effect on asthma symptoms when used alone, it is most often paired with a short-acting β<sub>2</sub>-adrenergic agonist. While it is considered a relief or rescue medication, it can take a full hour to begin working. For this reason, it plays a secondary role in acute asthma treatment. Dry throat is the most common side effect. If the medication gets in contact with the eyes, it may cause blurred vision for a brief time. The use of anticholinergics in combination with short-acting β<sub>2</sub>-adrenergic agonists has been shown to reduce hospital admissions in children and adults with acute asthma exacerbations.<ref>{{cite journal | vauthors = Rodrigo GJ, Castro-Rodriguez JA | title = Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis | journal = Thorax | volume = 60 | issue = 9 | pages = 740–6 | date = September 2005 | pmid = 16055613 | pmc = 1747524 | doi = 10.1136/thx.2005.040444 }}</ref><ref>{{cite journal | vauthors = Griffiths B, Ducharme FM | title = Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children | journal = Paediatric Respiratory Reviews | volume = 14 | issue = 4 | pages = 234–5 | date = December 2013 | pmid = 24070913 | doi = 10.1016/j.prrv.2013.08.002 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)